IMPORTANT NOTICE: Our email addresses will soon change. Learn more >>
Loading...

PE anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_PE_090808.jpg
C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
  • 1A8_PE_090808.jpg
    C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
127607 50 µg $134
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127608 200 µg $283
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  3. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  4. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  5. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  6. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  7. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  8. MacLean AJ, et al. 2022. Immunity. 55:718. PubMed
  9. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  10. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  11. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  12. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  13. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  14. Hopke A, et al. 2022. iScience. 25:105226. PubMed
  15. Nagre N, et al. 2022. Respir Res. 23:326. PubMed
  16. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  17. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  18. Pinto NA, et al. 2023. Cell Death Differ. :. PubMed
  19. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  20. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  21. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  22. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  23. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  24. Kraynak CA, et al. 2022. Int J Pharm. 618:121634. PubMed
  25. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  26. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  27. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  28. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  29. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  30. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  31. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  32. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  33. Cozzolino M, et al. 2023. Int J Mol Sci. 24:. PubMed
  34. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  35. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  36. Roy S, et al. 2023. J Clin Invest. 133:. PubMed
  37. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  38. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  39. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  40. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  41. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  42. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  43. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  44. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  45. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  46. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  47. Cai B, et al. 2016. Proc Natl Acad Sci U S A. 113: 6526 - 6531. PubMed
  48. Kozik J, et al. 2016. Sci Rep. 6:28556. PubMed
  49. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  50. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  51. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  52. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  53. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  54. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  55. Gawish R, et al. 2022. Elife. 11:. PubMed
  56. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  57. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  58. Ancey PB, et al. 2021. Cancer Res. 81:2345. PubMed
  59. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  60. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  61. Ajendra J, et al. 2016. Sci Rep. 6:39648. PubMed
  62. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  63. Putnam NE, et al. 2019. PLoS Pathog. 15:e1007744. PubMed
  64. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  65. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  66. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  67. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  68. Bottek J, et al. 2020. Mucosal Immunol. 1.029166667. PubMed
  69. Sharma K, et al. 2021. Cell Reports. 36(3):109351. PubMed
  70. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  71. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  72. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  73. Sun P, et al. 2015. J Hepatol. . PubMed
  74. Okada M, et al. 2014. J Biol Chem. 289:32926. PubMed
  75. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  76. Ishii T,et al. 2017. Sci Rep.. 10.1038/s41598-017-12513-1. PubMed
  77. Xie D, et al. 2017. PLoS One. 10.1371/journal.pone.0181454. PubMed
  78. Muhammad W, et al. 2022. Acta Biomater. 148:258. PubMed
  79. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  80. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  81. Harding M, et al. 2014. PLoS Pathog. 10:1004379. PubMed
  82. Morales D, et al. 2015. J Virol. 89:337. PubMed
  83. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  84. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  85. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  86. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  87. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  88. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  89. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  90. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  91. Yeo WS, et al. 2020. J Bacteriol. 202:00:00. PubMed
  92. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  93. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  94. Lemon J, et al. 2015. Infect Immun . 83: 3204-3212. PubMed
  95. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  96. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  97. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  98. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  99. Metzger D, et al. 2015. J Infect Dis. 212: 445-452. PubMed
  100. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  101. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  102. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  103. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  104. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  105. Winkler MJ, et al. 2020. Basic Res Cardiol. 115:67. PubMed
  106. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  107. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  108. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  109. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  110. Kojo K, et al. 2016. Sci Rep. 6:29650. PubMed
  111. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  112. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  113. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  114. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  115. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  116. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  117. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  118. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  119. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  120. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  121. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  122. Catani J, et al. 2016. Transl Oncol. 9:565-574. PubMed
  123. Markman JL, et al. 2020. Nat Commun. 11:1613. PubMed
  124. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  125. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  126. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  127. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  128. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  129. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  130. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  131. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  132. Su M, et al. 2022. Nat Cardiovasc Res. 1:732. PubMed
  133. Umeshappa CS, et al. 2021. Cell Reports. 34(13):108919. PubMed
  134. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  135. Finsterbusch M, et al. 2014. J Exp Med. 211:1307. PubMed
  136. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  137. Kim Y, et al. 2012. J Immunol. 188:4226. PubMed
  138. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  139. Rynkiewicz NK, et al. 2020. Sci Signal. 13:. PubMed
  140. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  141. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  142. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  143. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  144. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  145. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  146. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  147. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  148. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  149. Kimura H, et al. 2019. Sci Rep. 9:5887. PubMed
  150. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  151. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  152. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  153. Takizawa S, et al. 2022. Mol Med. 28:91. PubMed
  154. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  155. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  156. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  157. Kim M, et al. 2018. Immunity. 49:151. PubMed
  158. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  159. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  160. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  161. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
  162. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  163. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  164. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
  165. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  166. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  167. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  168. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  169. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  170. Eislmayr K, et al. 2022. Sci Adv. 8:eabj7293. PubMed
  171. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  172. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  173. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  174. Huang W, et al. 2016. Cell Death Differ. 10.1038/cdd.2016.115. PubMed
  175. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  176. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  177. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  178. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  179. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  180. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  181. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  182. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  183. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  184. Issah Y, et al. 2021. Elife. 10:. PubMed
  185. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  186. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  187. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  188. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  189. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  190. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  191. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  192. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  193. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  194. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  195. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  196. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  197. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  198. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  199. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  200. Guo H, et al. 2016. J Immunol. 196: 2300 - 2308. PubMed
  201. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  202. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  203. Moraes JA, et al. 2018. J Innate Immun. 11:330. PubMed
  204. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  205. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  206. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  207. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  208. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  209. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  210. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  211. Hou Y, et al. 2013. J Nutr Biochem. 24:1555. PubMed
  212. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  213. Wang C, et al. 2020. Mucosal Immunol. 13:22. PubMed
  214. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  215. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  216. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  217. Zha ZX, et al. 2022. Acta Pharmacol Sin. :. PubMed
  218. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  219. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  220. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  221. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  222. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  223. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  224. Rodgers M, et al. 2014. J Exp Med. 211:1333. PubMed
  225. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  226. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  227. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  228. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  229. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  230. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  231. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
RRID
AB_1186099 (BioLegend Cat. No. 127607)
AB_1186099 (BioLegend Cat. No. 127608)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Spark Red™ 718 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Spark Blue™ 574 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
PerCP/Fire™ 806 anti-mouse Ly-6G 1A8 FC
Go To Top Version: 3    Revision Date: 01/06/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account